egSEQ Haematology Panel is a RNA-based hybridisation targeted sequencing panel. The comprehensive panel targets 141 common fusion genes in haematological tumours, such as KMT2A, RARα and NUP98, providing accurate, comprehensive and cost-effective analyses for haematology diagnosis, treatment, prognosis and monitoring.
Expertly curated coverage covers a comprehensive range of hotspot genes in the gonadotrophic, myeloid lineages, as well as unknown lineages.
Innovative RNA capture technology with enhanced performance for detecting low abundance transcripts and fusion genes.
Detection of fusions, variants and gene expression information in blood tumours at the RNA level.
Disease diagnosis, treatment, prognosis and recurrence monitoring.